• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成环丁烷类似物 4:嘌呤和嘧啶碳环核苷衍生物的制备。

Synthesis of Cyclobutane Analogue 4: Preparation of Purine and Pyrimidine Carbocyclic Nucleoside Derivatives.

机构信息

Department of Chemistry, Faculty of Science, York University, Toronto, ON M3J 1P3, Canada.

Chemistry Department, Faculty of Science, Arish University, Arish, Egypt.

出版信息

Molecules. 2019 Sep 5;24(18):3235. doi: 10.3390/molecules24183235.

DOI:10.3390/molecules24183235
PMID:31491981
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6767184/
Abstract

The coupling of 2-bromo-3-benzoyloxycyclobutanone with purine under basic conditions produces two regioisomers consisting of the and alkylated products in equal amounts in their racemic forms. The distribution of the isomers is consistent with the charge delocalization between the and positions of the purinyl anion. The structural assignments and relative stereochemistry of each regioisomer were based on 1 and 2D NMR techniques. The relative stereochemistry of the and substituents in each regioisomer was the orientation consistent with steric factors in the coupling step. The regioisomer was reduced with sodium borohydride to give the all cyclobutanol as the major product in a stereoselective manner. The alcohol was debenzoylated with sodium methoxide in a transesterification step to give the nucleoside analogue. The regioisomeric pyrimidine nucleosides were prepared by Vorbrüggen coupling of the 3-hydroxymethylcyclobutanone triflate with either thymine or uracil followed by stereoselective hydride addition. Regiospecificity of the coupling at the N-1 position was observed and stereoselective reduction to the trans-disubstituted cyclobutanol structure assignments was based on NMR data.

摘要

在碱性条件下,2-溴-3-苯甲酰基环丁酮与嘌呤偶联,生成两种比例相等的非对映异构体,即和烷基化产物。异构体的分布与嘌呤阴离子的和位置之间的电荷离域一致。每个区域异构体的结构分配和相对立体化学都是基于 1 和 2D NMR 技术。每个区域异构体中和取代基的相对立体化学是与偶联步骤中的空间因素一致的 取向。用硼氢化钠还原 区域异构体,以立体选择性方式得到主要产物全 环丁醇。在转酯化步骤中,用甲醇钠脱去 区域异构体的苯甲酰基,得到核苷类似物。通过 3-羟甲基环丁酮三氟甲磺酸酯与胸腺嘧啶或尿嘧啶的 Vorbrüggen 偶联,制备了区域异构体嘧啶核苷,然后进行立体选择性氢化加成。在 N-1 位置观察到偶联的区域特异性,并基于 NMR 数据对立体选择性还原到反式二取代环丁醇结构分配进行了评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/d83c2317d410/molecules-24-03235-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/88c3c93dc943/molecules-24-03235-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/98fcf08a98df/molecules-24-03235-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/bfdd76fa4503/molecules-24-03235-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/4f46e246a3fe/molecules-24-03235-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/688a633b7636/molecules-24-03235-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/2e976e9c95a8/molecules-24-03235-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/057358455603/molecules-24-03235-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/d637c21a27f4/molecules-24-03235-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/935961b3ff6d/molecules-24-03235-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/5dabb0867a67/molecules-24-03235-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/f30ef3a7c2a8/molecules-24-03235-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/204f1eab6574/molecules-24-03235-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/a8a3628c7cbc/molecules-24-03235-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/31e509a537a8/molecules-24-03235-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/34de800fe0e0/molecules-24-03235-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/6d811815da97/molecules-24-03235-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/d83c2317d410/molecules-24-03235-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/88c3c93dc943/molecules-24-03235-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/98fcf08a98df/molecules-24-03235-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/bfdd76fa4503/molecules-24-03235-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/4f46e246a3fe/molecules-24-03235-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/688a633b7636/molecules-24-03235-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/2e976e9c95a8/molecules-24-03235-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/057358455603/molecules-24-03235-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/d637c21a27f4/molecules-24-03235-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/935961b3ff6d/molecules-24-03235-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/5dabb0867a67/molecules-24-03235-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/f30ef3a7c2a8/molecules-24-03235-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/204f1eab6574/molecules-24-03235-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/a8a3628c7cbc/molecules-24-03235-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/31e509a537a8/molecules-24-03235-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/34de800fe0e0/molecules-24-03235-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/6d811815da97/molecules-24-03235-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6767184/d83c2317d410/molecules-24-03235-sch006.jpg

相似文献

1
Synthesis of Cyclobutane Analogue 4: Preparation of Purine and Pyrimidine Carbocyclic Nucleoside Derivatives.合成环丁烷类似物 4:嘌呤和嘧啶碳环核苷衍生物的制备。
Molecules. 2019 Sep 5;24(18):3235. doi: 10.3390/molecules24183235.
2
Synthesis of cyclobutane nucleoside analogues 3: Preparation of carbocyclic derivatives of oxetanocin.环丁烷核苷类似物3的合成:氧杂环丁烷菌素的碳环衍生物的制备。
Nucleosides Nucleotides Nucleic Acids. 2018;37(9):518-531. doi: 10.1080/15257770.2018.1500697. Epub 2018 Sep 6.
3
Synthesis of cyclobutane nucleosides 2-preparation of thymine and uracil analogues.环丁烷核苷的合成2-胸腺嘧啶和尿嘧啶类似物的制备
Nucleosides Nucleotides Nucleic Acids. 2015;34(11):786-98. doi: 10.1080/15257770.2015.1075551. Epub 2015 Sep 23.
4
Synthesis of racemic and enantiomeric 3-pyrrolidinyl derivatives of purine and pyrimidine nucleobases.嘌呤和嘧啶核碱基的外消旋和对映体3-吡咯烷基衍生物的合成。
Nucleosides Nucleotides Nucleic Acids. 2005;24(5-7):805-8. doi: 10.1081/ncn-200060287.
5
Synthesis and conformational analysis of new cyclobutane-fused nucleosides.新型环丁烷稠合核苷的合成与构象分析
Org Lett. 2006 Feb 2;8(3):491-4. doi: 10.1021/ol052794y.
6
Synthetic strategies toward carbocyclic purine-pyrimidine hybrid nucleosides.合成碳环嘌呤 - 嘧啶杂合核苷的策略。
Bioorg Med Chem. 2009 Aug 1;17(15):5520-5. doi: 10.1016/j.bmc.2009.06.039. Epub 2009 Jun 23.
7
Stereoselective formation of a cyclobutane pyrimidine dimer by using N4-acetyl protection of the cytosine base.通过对胞嘧啶碱基进行N4-乙酰基保护实现环丁烷嘧啶二聚体的立体选择性形成。
Nucleic Acids Symp Ser (Oxf). 2008(52):437-8. doi: 10.1093/nass/nrn222.
8
Investigation of 8-Aza-7-Deaza Purine Nucleoside Derivatives.8-氮杂-7-去氮嘌呤核苷衍生物的研究。
Molecules. 2019 Mar 11;24(5):983. doi: 10.3390/molecules24050983.
9
Synthesis of cyclobutane nucleosides.环丁烷核苷的合成。
Nucleosides Nucleotides Nucleic Acids. 2011 Jun;30(6):391-404. doi: 10.1080/15257770.2011.584513.
10
Cyclopentane-nucleobase coupling in the synthesis of carbocyclic L-nucleosides: is a SN2-reaction an alternative to the Mitsunobu-reaction?碳环L-核苷合成中环戊烷-核苷酸碱基偶联反应:SN2反应能否替代 Mitsunobu 反应?
Nucleosides Nucleotides Nucleic Acids. 2007;26(8-9):1181-4. doi: 10.1080/15257770701527745.

引用本文的文献

1
Discovery, Design, Synthesis, and Application of Nucleoside/Nucleotides.核苷/核苷酸的发现、设计、合成及应用。
Molecules. 2020 Mar 27;25(7):1526. doi: 10.3390/molecules25071526.

本文引用的文献

1
Synthesis of cyclobutane nucleoside analogues 3: Preparation of carbocyclic derivatives of oxetanocin.环丁烷核苷类似物3的合成:氧杂环丁烷菌素的碳环衍生物的制备。
Nucleosides Nucleotides Nucleic Acids. 2018;37(9):518-531. doi: 10.1080/15257770.2018.1500697. Epub 2018 Sep 6.
2
Synthesis, conformational study and antiviral activity of l-like neplanocin derivatives.L-型新制癌菌素衍生物的合成、构象研究及抗病毒活性
Bioorg Med Chem Lett. 2017 Sep 15;27(18):4436-4439. doi: 10.1016/j.bmcl.2017.08.009. Epub 2017 Aug 7.
3
Synthesis of cyclobutane nucleosides.
环丁烷核苷的合成。
Nucleosides Nucleotides Nucleic Acids. 2011 Jun;30(6):391-404. doi: 10.1080/15257770.2011.584513.
4
Expedient approach to chiral cyclobutanones: asymmetric synthesis of cyclobut-G.手性环丁酮的便捷合成方法:环丁-G的不对称合成
Org Lett. 2008 Mar 6;10(5):821-4. doi: 10.1021/ol702977x. Epub 2008 Feb 13.
5
Stereoselective route to oxetanocin carbocyclic analogues based on a [2 + 2] photocycloaddition to a chiral 2(5H)-furanone.基于对手性2(5H)-呋喃酮的[2 + 2]光环加成反应的氧杂环丁烷碳环类似物的立体选择性合成路线。
Org Lett. 2007 Jul 19;9(15):2827-30. doi: 10.1021/ol0710616. Epub 2007 Jun 21.
6
Strategies in the design of antiviral drugs.抗病毒药物的设计策略。
Nat Rev Drug Discov. 2002 Jan;1(1):13-25. doi: 10.1038/nrd703.
7
Antiviral efficacy of lobucavir (BMS-180194), a cyclobutyl-guanosine nucleoside analogue, in the woodchuck (Marmota monax) model of chronic hepatitis B virus (HBV) infection.环丁基鸟苷核苷类似物洛布卡韦(BMS - 180194)在慢性乙型肝炎病毒(HBV)感染土拨鼠(Marmota monax)模型中的抗病毒疗效。
Antiviral Res. 2000 Dec;48(3):197-203. doi: 10.1016/s0166-3542(00)00128-5.
8
Regioselective enzymatic aminoacylation of lobucavir to give an intermediate for lobucavir prodrug.洛布卡韦的区域选择性酶促氨酰化反应以制备洛布卡韦前药的中间体。
Bioorg Med Chem. 2000 Dec;8(12):2681-7. doi: 10.1016/s0968-0896(00)00209-1.
9
Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89.强效抗人类免疫缺陷病毒药物1592U89的独特细胞内激活作用
Antimicrob Agents Chemother. 1997 May;41(5):1099-107. doi: 10.1128/AAC.41.5.1099.
10
Inhibition of infectivity of human immunodeficiency virus by oxetanocin.氧杂环丁烷对人类免疫缺陷病毒感染性的抑制作用。
J Antibiot (Tokyo). 1987 Jul;40(7):1077-8. doi: 10.7164/antibiotics.40.1077.